Skip to main content

Table 1 General characteristics of the study subjects

From: Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer

Characteristics

Discovery set

Replication set

 

(n = 48)

(n = 97)

Age group

 < 50 years

26(54.2%)

22(45.8%)

 ≥ 50 years

48(49.5%)

49(50.5%)

Stage

 Stage I

11(22.9%)

25(25.8%)

 Stage II

37(77.1%)

72(74.2%)

 Stage IIA

26

50

 Stage IIB

11

22

ER status

 Positive

25(52.1%)

54(55.7%)

 Negative

23(47.9%)

43(44.3%)

PR status

  

 Positive

35(72.9%)

59(60.8%)

 Negative

13(27.1%)

38(39.2%)

HER2 status

 Positive

11(22.9%)

23(23.7%)

 Negative

37(77.1%)

74(76.3%)

Subtype

  

 Luminal A

29(60.4%)

53(54.6%)

 Luminal B

10(20.8%)

16(16.5%)

 HER2

1(2.1%)

7(7.2%)

 TNBC

8(16.7%)

21(21.6%)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us